Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.90
Bid: 297.20
Ask: 297.40
Change: -5.40 (-1.79%)
Spread: 0.20 (0.067%)
Open: 301.70
High: 302.90
Low: 295.20
Prev. Close: 302.30
MKS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Blocklisting Interim Review

18 Jan 2012 16:26

RNS Number : 7967V
Marks & Spencer Group PLC
18 January 2012
 



BLOCK LISTING SIX MONTHLY RETURN

 

The following information is released in accordance with LR 3.5.6

 

To: The FSA

 

Date: 18 January 2012

 

Name of applicant:

MARKS AND SPENCER GROUP PLC

Name of scheme:

SAYE SCHEME

Period of Return:

From:

1 JULY 2011

To:

31 DEC 2011

Balance under scheme from previous return:

59,280,492 SHARES

The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return:

N/A

Number of securities issued/allotted under scheme during period:

160,304

Balance under scheme not yet issued/allotted at end of period

59,120,188

Number and class of securities originally listed and the date of admission

ORDINARY SHARES OF 25P EACH

20,859,113 SHARES LISTED ON

19 MARCH 2002

30,000,000 SHARES LISTED ON

25 NOVEMBER 2004

20,000,000 SHARES LISTED ON

10 NOVEMBER 2006

40,000,000 SHARES LISTED ON

10 NOVEMBER 2009

Total number of securities in issue at the end of the period (30 June 2011)

1,585,395,724

 

Name of contact:

ANTHONY CLARKE

Address of contact:

MARKS AND SPENCER GROUP PLC

WATERSIDE HOUSE

35 NORTH WHARF ROAD

LONDON, W2 1NW

Telephone number of contact:

020 8718 9940

 

SIGNED BY ANTHONY CLARKE____________________________________________

Director/company secretary/suitably experienced employee/duly authorised officer, for and on behalf of

 

MARKS AND SPENCER GROUP PLC____________________

Name of applicant

 

If you knowingly or recklessly give false or misleading information you may be liable to prosecution.

 

 

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

The following information is released in accordance with LR 3.5.6

 

To: The FSA

 

Date: 18 January 2012

 

Name of applicant:

MARKS AND SPENCER GROUP PLC

Name of scheme:

SENIOR OPTION SCHEME

Period of Return:

From:

1 JULY 2011

To:

31 DEC 2011

Balance under scheme from previous return:

6,892,189 SHARES

The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return:

N/A

Number of securities issued/allotted under scheme during period:

0

Balance under scheme not yet issued/allotted at end of period

6,829,189

Number and class of securities originally listed and the date of admission

ORDINARY SHARES OF 25P EACH

23,303,606 SHARES LISTED ON

19 MARCH 2002

27,000,000 SHARES LISTED ON

25 NOVEMBER 2004

Total number of securities in issue at the end of the period (30 June 2011)

1,585,395,724

 

Name of contact:

ANTHONY CLARKE

Address of contact:

MARKS AND SPENCER GROUP PLC

WATERSIDE HOUSE

35 NORTH WHARF ROAD

LONDON, W2 1NW

Telephone number of contact:

020 8718 9940

 

SIGNED BY ANTHONY CLARKE____________________________________________

Director/company secretary/suitably experienced employee/duly authorised officer, for and on behalf of

 

MARKS AND SPENCER GROUP PLC____________________

Name of applicant

 

If you knowingly or recklessly give false or misleading information you may be liable to prosecution.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRBLGDBSDBBGDI
Date   Source Headline
3rd Jun 202410:00 amRNSAnnual Financial Report
3rd Jun 20249:00 amRNSTotal Voting Rights
30th May 202412:41 pmRNSDirector/PDMR Shareholding
29th May 20244:01 pmRNSCFO announcement
29th May 20242:07 pmRNSDirector/PDMR Shareholding
28th May 20242:04 pmRNSAndrew Fisher to stand down from the Board
22nd May 20247:00 amRNSFinal Results
1st May 20249:00 amRNSTotal Voting Rights
30th Apr 20241:13 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:00 amRNSTotal Voting Rights
28th Mar 20245:23 pmRNSHolding(s) in Company
28th Mar 20243:07 pmRNSDirector/PDMR Shareholding
26th Mar 20243:07 pmRNSDirector/PDMR Shareholding
7th Mar 20243:16 pmRNSHolding(s) in Company
7th Mar 20248:40 amRNSKatie Bickerstaffe - Planned Leadership Evolution
4th Mar 20243:11 pmRNSDirector/PDMR Shareholding
1st Mar 20249:00 amRNSTotal Voting Rights
28th Feb 20241:43 pmRNSDirector/PDMR Shareholding
16th Feb 20249:00 amRNSDirector Declaration
1st Feb 20249:00 amRNSTotal Voting Rights
30th Jan 20242:53 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
15th Jan 20242:36 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSChristmas 2023/2024 Trading
10th Jan 20243:28 pmRNSChange To Board Committee Membership
5th Jan 20244:23 pmRNSHolding(s) in Company
2nd Jan 20249:00 amRNSBlock listing Interim Review
2nd Jan 20249:00 amRNSTotal Voting Rights
28th Dec 202311:40 amRNSDirector/PDMR Shareholding
20th Dec 202311:36 amRNSHolding(s) in Company
19th Dec 202310:30 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSAdditional Listing
12th Dec 20239:13 amRNSDirector/PDMR Shareholding
1st Dec 20239:00 amRNSTotal Voting Rights
28th Nov 20232:55 pmRNSDirector/PDMR Shareholding
9th Nov 202310:29 amRNSDirector/PDMR Shareholding
8th Nov 20237:00 amRNSHalf-year Report
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:01 pmRNSDirector/PDMR Shareholding
2nd Oct 20239:00 amRNSTotal Voting Rights
28th Sep 20233:18 pmRNSDirector/PDMR Shareholding
20th Sep 20233:33 pmRNSHolding(s) in Company
20th Sep 20239:00 amRNSDirector/PDMR Shareholding
19th Sep 20239:01 amRNSDirector/PDMR Shareholding
1st Sep 20239:00 amRNSTotal Voting Rights
30th Aug 202310:34 amRNSDirector/PDMR Shareholding
16th Aug 20233:00 pmRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSTrading Update and Outlook for the Year
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 202311:33 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.